Pregnancy Related Clinical Trial
— EASI-AOfficial title:
Early Antenatal Support for Iron Deficiency Anemia: A Randomized Controlled Trial of Early Initiation of Intravenous Versus Oral Iron Therapy for Treatment of Iron Deficiency Anemia in Pregnancy
This is a randomized, controlled multi-site trial of iron therapy in pregnancy. The purpose of this research is to see if second trimester initiation of intravenous (IV) iron therapy is better than oral iron therapy for treatment of anemia in pregnancy by improving blood count, quality of life and reducing side effects.
Status | Recruiting |
Enrollment | 80 |
Est. completion date | December 30, 2025 |
Est. primary completion date | August 30, 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years to 65 Years |
Eligibility | Inclusion Criteria: - Singleton gestation - Gestational age <24 weeks - Baseline Hb =9.0 and <11.0 with evidence of iron deficiency anemia Iron deficiency anemia diagnosed (at any point in patient history) by: - Hb<11.0 - Ferritin<30 and/or total iron saturation <20 Exclusion Criteria: - Sickle cell Disease (NOT sickle cell trait) - Evidence of acute anemia requiring transfusion or IV iron therapy - Major congenital or chromosomal anomaly - Previous use of IV iron in this pregnancy - Severe cardiac, renal, or liver disease - Autoimmune disease (ie Systemic Lupus Erythematosus (SLE) - Allergy or contraindication to either study drug - History of medication allergy, reaction to IV infusion, or reaction to Feraheme or other IV iron products |
Country | Name | City | State |
---|---|---|---|
United States | Thomas Jefferson University Hospital | Philadelphia | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Thomas Jefferson University | Auerbach Hematology and Oncology |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change in Hemoglobin | Change in hemoglboin at day 90 following treatment initiation | 90 days | |
Secondary | Anemia resolution | Percent of participants in each group with Hb>=11.0 at day 90 | 90 days | |
Secondary | Anemia at Delivery | Percent of participants in each group with Hb>=11.0 at delivery | 9 months | |
Secondary | Need for additional therapy | Percent of participants in each group requiring additional therapy for iron deficiency anemia after 28 weeks | 9 months | |
Secondary | Quality of life scale | Linear Analogue Scale Assessment | 30, 60, 90 days | |
Secondary | Adherence | adherence to assigned group. Measured by what % of IV infusions completed of the two required in IV iron group, and for oral iron group, what %pills taken/prescribed based on pill counts | 90 days | |
Secondary | Need for post partum transfusion | Incidence of transfusion after delivery/post partum | 9 months | |
Secondary | Neonatal outcomes: cord blood iron indices | Hb, ferritin, total iron saturation | 9 months | |
Secondary | Neonatal outcomes: birth weight | birth weight (grams) | 9 months | |
Secondary | Neonatal outcomes gestational age of delivery (weeks) | gestational age of delivery (weeks) | 9 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A | |
Not yet recruiting |
NCT04960800 -
Effect of a Specific Exercise Program During Pregnancy on Diastasis Recti Abdominis
|
N/A |